pharmaceuticals
pharmaceuticals Articles
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Published:
Last Updated:
EyeGate Pharmaceuticals shares rose about 10% on Monday after the company announced promising data from its mid-stage trial of its leading product candidate.
Published:
Last Updated:
GW Pharmaceuticals reported its fiscal fourth-quarter financial results before the markets opened on Monday.
Published:
Last Updated:
Shares of Cempra saw a handy gain early Monday after Toyama Chemical announced that it had begun Phase 3 clinical trials with solithromycin in Japan for patients with respiratory infections.
Published:
Last Updated:
Recro Pharma saw its shares fall on Thursday after the company announced a secondary offering. This follows the company's recent win in its late-stage IV metoxicam trial.
Published:
Last Updated:
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
Published:
Last Updated:
TiGenix has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced...
Published:
Last Updated:
Recro Pharma shares saw a handy gain on Monday after the company announced positive late-stage results on its acute postoperative pain treatment.
Published:
Last Updated:
Juno Therapeutics Inc. (NASDAQ: JUNO) saw its shares hit a new 52-week low in Wednesday’s session after the company announced a clinical hold on its JCAR015 trial. The company announced that it has...
Published:
Last Updated:
Eli Lilly & Co. (NYSE: LLY) is watching its shares in free fall on Wednesday, not from any election or political concerns but a late-stage trial failure. As we have said time and again, clinical...
Published:
Last Updated:
Aclaris Therapeutics saw its shares make a handy gain on Friday after the company announced the pricing of its secondary offering.
Published:
Last Updated:
Eyegate Pharmaceuticals saw its shares make a strong gain to close out the week after the company announced an update from its meeting with the FDA.
Published:
Last Updated:
With the market effectively at all-time highs after the election, investors are looking for new ideas to generate income or gains ahead. Sometimes investors turn to Wall Street research to look for...
Published:
Last Updated:
Shares of Aurinia Pharmaceuticals saw a handy gain on Wednesday after the company gave an update on its lupus nephritis treatment.
Published:
Last Updated: